{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T09:46:07Z","timestamp":1778233567859,"version":"3.51.4"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T00:00:00Z","timestamp":1633910400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T00:00:00Z","timestamp":1633910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Microbiol Biotechnol"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s11274-021-03158-4","type":"journal-article","created":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T06:51:04Z","timestamp":1633935064000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["In vitro study on the potential fungicidal effects of atorvastatin in combination with some azole drugs against multidrug resistant Candida albicans"],"prefix":"10.1007","volume":"37","author":[{"given":"Dina Ezzat","family":"Mahmoud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed Hassan Ibrahim","family":"Faraag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7885-997X","authenticated-orcid":false,"given":"Wael Mohamed","family":"Abu El-Wafa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,11]]},"reference":[{"key":"3158_CR1","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1093\/BIOINFORMATICS\/BTQ662","volume":"27","author":"P Benkert","year":"2011","unstructured":"Benkert P, Biasini M, Schwede T (2011) Toward the estimation of the absolute quality of individual protein structure models. Bioinformatics 27:343\u2013350. https:\/\/doi.org\/10.1093\/BIOINFORMATICS\/BTQ662","journal-title":"Bioinformatics"},{"key":"3158_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/S41598-017-09654-8","author":"M Bertoni","year":"2017","unstructured":"Bertoni M, Kiefer F, Biasini M et al (2017) Modeling protein quaternary structure of homo- and hetero-oligomers beyond binary interactions by homology. Sci Rep. https:\/\/doi.org\/10.1038\/S41598-017-09654-8","journal-title":"Sci Rep"},{"key":"3158_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/antibiotics9060312","volume":"9","author":"S Bhattacharya","year":"2020","unstructured":"Bhattacharya S, Sae-Tia S, Fries BC (2020) Candidiasis and mechanisms of antifungal resistance. Antibiotics 9:1\u201319. https:\/\/doi.org\/10.3390\/antibiotics9060312","journal-title":"Antibiotics"},{"key":"3158_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/jof3040057","author":"F Bongomin","year":"2017","unstructured":"Bongomin F, Gago S, Oladele RO, Denning DW (2017) Global and multi-national prevalence of fungal diseases\u2014estimate precision. J Fungi. https:\/\/doi.org\/10.3390\/jof3040057","journal-title":"J Fungi"},{"key":"3158_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.riam.2012.09.006","volume":"30","author":"ME Cabral","year":"2013","unstructured":"Cabral ME, Figueroa LIC, Fari\u00f1a JI (2013) Synergistic antifungal activity of statin-azole associations as witnessed by Saccharomyces cerevisiae- and Candida utilis-bioassays and ergosterol quantification. Rev Iberoam Micol 30:31\u201338. https:\/\/doi.org\/10.1016\/j.riam.2012.09.006","journal-title":"Rev Iberoam Micol"},{"key":"3158_CR6","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/J.BCP.2016.11.019","volume":"133","author":"S Campoy","year":"2017","unstructured":"Campoy S, Adrio JL (2017) Antifungals. Biochem Pharmacol 133:86\u201396. https:\/\/doi.org\/10.1016\/J.BCP.2016.11.019","journal-title":"Biochem Pharmacol"},{"key":"3158_CR7","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1128\/AAC.50.1.96-103.2006","volume":"50","author":"G Chamilos","year":"2006","unstructured":"Chamilos G, Lewis RE, Kontoyiannis DP (2006) Lovastatin has significant activity against zygomycetes and interacts synergistically with voriconazole. Antimicrob Agents Chemother 50:96\u2013103. https:\/\/doi.org\/10.1128\/AAC.50.1.96-103.2006","journal-title":"Antimicrob Agents Chemother"},{"key":"3158_CR8","unstructured":"CLSI. (2017) Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Seventh Informational Supplement. CLSI Document M100-S27."},{"key":"3158_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8020154","author":"S Costa-de-oliveira","year":"2020","unstructured":"Costa-de-oliveira S, Rodrigues AG (2020) Candida albicans antifungal resistance and tolerance in bloodstream infections: the triad yeast-host-antifungal. Microorganisms. https:\/\/doi.org\/10.3390\/microorganisms8020154","journal-title":"Microorganisms"},{"key":"3158_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0242542","volume":"15","author":"S Darma","year":"2020","unstructured":"Darma S, Ambara A, Aman AT et al (2020) High frequency of azole resistant Candida spp. colonization among presumptive multidrug resistant tuberculosis (MDR-TB) patients. PLoS One 15:1\u201312. https:\/\/doi.org\/10.1371\/journal.pone.0242542","journal-title":"PLoS One"},{"key":"3158_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0226467","volume":"15","author":"G De Angelis","year":"2020","unstructured":"De Angelis G, Menchinelli G, Torelli R et al (2020) Different detection capabilities by mycological media for Candida isolates from mono- or dual-species cultures. PLoS One 15:1\u20139. https:\/\/doi.org\/10.1371\/journal.pone.0226467","journal-title":"PLoS One"},{"key":"3158_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/FCHEM.2020.00516","author":"E Di Bello","year":"2020","unstructured":"Di Bello E, Zwergel C, Mai A, Valente S (2020) The innovative potential of statins in cancer: new targets for new therapies. Front Chem. https:\/\/doi.org\/10.3389\/FCHEM.2020.00516","journal-title":"Front Chem"},{"key":"3158_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.21608\/aps.2019.20210","volume":"3","author":"H El-Houssaini","year":"2019","unstructured":"El-Houssaini H, Elkhatib W, Elnabawy O, Nasser H (2019) Antifungal resistance and predominance of virulence determinants among Candida albicans isolated from various clinical specimens. Arch Pharm Sci Ain Shams Univ 3:11\u201320. https:\/\/doi.org\/10.21608\/aps.2019.20210","journal-title":"Arch Pharm Sci Ain Shams Univ"},{"key":"3158_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-64571-7","volume":"10","author":"HE Eldesouky","year":"2020","unstructured":"Eldesouky HE, Salama EA, Li X et al (2020) Repurposing approach identifies pitavastatin as a potent azole chemosensitizing agent effective against azole-resistant Candida species. Sci Rep 10:1\u201312. https:\/\/doi.org\/10.1038\/s41598-020-64571-7","journal-title":"Sci Rep"},{"key":"3158_CR15","doi-asserted-by":"publisher","unstructured":"Esfahani AN, Golestannejad Z, Khozeimeh F, et al (2019) Antifungal effect of Atorvastatin against Candida species in comparison to Fluconazole and Nystatin. Med Pharm Reports 92:368\u2013373. https:\/\/doi.org\/10.15386\/mpr-1209","DOI":"10.15386\/mpr-1209"},{"key":"3158_CR16","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1128\/AAC.02456-15","volume":"60","author":"A Espinel-Ingroff","year":"2016","unstructured":"Espinel-Ingroff A, Colombo AL, Cordoba S et al (2016) International evaluation of MIC distributions and epidemiological cutoff value (ECV) definitions for Fusarium species identified by molecular methods for the CLSI broth microdilution method. Antimicrob Agents Chemother 60:1079\u20131084. https:\/\/doi.org\/10.1128\/AAC.02456-15","journal-title":"Antimicrob Agents Chemother"},{"key":"3158_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/jof5030067","author":"DZP Friedman","year":"2019","unstructured":"Friedman DZP, Schwartz IS (2019) Emerging fungal infections: new patients, new patterns, and new pathogens. J Fungi. https:\/\/doi.org\/10.3390\/jof5030067","journal-title":"J Fungi"},{"key":"3158_CR18","doi-asserted-by":"publisher","first-page":"6177","DOI":"10.1021\/JM051256O","volume":"49","author":"RA Friesner","year":"2006","unstructured":"Friesner RA, Murphy RB, Repasky MP et al (2006) Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J Med Chem 49:6177\u20136196. https:\/\/doi.org\/10.1021\/JM051256O","journal-title":"J Med Chem"},{"key":"3158_CR19","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3390\/jof6010028","volume":"6","author":"TJ Gintjee","year":"2020","unstructured":"Gintjee TJ, Donnelley MA, Thompson GR (2020) Aspiring antifungals: review of current antifungal pipeline developments. J Fungi 6:28. https:\/\/doi.org\/10.3390\/jof6010028","journal-title":"J Fungi"},{"key":"3158_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/elps.200900140","author":"N Guex","year":"2009","unstructured":"Guex N, Peitsch M, Electrophoresis TS (2009) undefined (2009) Automated comparative protein structure modeling with SWISS-MODEL and Swiss-PdbViewer: a historical perspective. Wiley Online Libr. https:\/\/doi.org\/10.1002\/elps.200900140","journal-title":"Wiley Online Libr"},{"key":"3158_CR21","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/J.ORALONCOLOGY.2019.01.019","volume":"90","author":"A Gupta","year":"2019","unstructured":"Gupta A, Stokes W, Eguchi M et al (2019) Statin use associated with improved overall and cancer specific survival in patients with head and neck cancer. Oral Oncol 90:54\u201366. https:\/\/doi.org\/10.1016\/J.ORALONCOLOGY.2019.01.019","journal-title":"Oral Oncol"},{"key":"3158_CR22","doi-asserted-by":"crossref","unstructured":"Hassan A, Usman J, Kaleem F, et al (2017) Evaluation of different detection methods of biofilm formation in the clinical isolates. Braz J Infect Dis 15:305\u201311","DOI":"10.1590\/S1413-86702011000400002"},{"key":"3158_CR23","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1128\/AAC.44.10.2693-2700.2000","volume":"44","author":"KW Henry","year":"2000","unstructured":"Henry KW, Nickels JT, Edlind TD (2000) Upregulation of ERG genes in Candida species by azoles and other sterol biosynthesis inhibitors. Antimicrob Agents Chemother 44:2693\u20132700. https:\/\/doi.org\/10.1128\/AAC.44.10.2693-2700.2000","journal-title":"Antimicrob Agents Chemother"},{"key":"3158_CR24","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/J.ARCMED.2020.10.021","volume":"52","author":"D Ju\u00e1rez-L\u00f3pez","year":"2021","unstructured":"Ju\u00e1rez-L\u00f3pez D, Schcolnik-Cabrera A (2021) Drug repurposing: considerations to surpass while re-directing old compounds for new treatments. Arch Med Res 52:243\u2013251. https:\/\/doi.org\/10.1016\/J.ARCMED.2020.10.021","journal-title":"Arch Med Res"},{"key":"3158_CR25","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01134-18","author":"MV Keniya","year":"2018","unstructured":"Keniya MV, Sabherwal M, Wilson RK et al (2018) Crystal structures of full-length lanosterol 14\u03b1-demethylases of prominent fungal pathogens candida albicans and candida glabrata provide tools for antifungal discovery. Antimicrob Agents Chemother. https:\/\/doi.org\/10.1128\/AAC.01134-18","journal-title":"Antimicrob Agents Chemother"},{"key":"3158_CR26","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.2147\/IDR.S196972","volume":"12","author":"SM Khairat","year":"2019","unstructured":"Khairat SM, Sayed AM, Nabih M et al (2019) Prevalence of Candida blood stream infections among children in tertiary care hospital: detection of species and antifungal susceptibility. Infect Drug Resist 12:2409\u20132416. https:\/\/doi.org\/10.2147\/IDR.S196972","journal-title":"Infect Drug Resist"},{"key":"3158_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/antibiotics9110812","volume":"9","author":"JH Kim","year":"2020","unstructured":"Kim JH, Cheng LW, Chan KL et al (2020) Antifungal drug repurposing. Antibiotics 9:1\u201329. https:\/\/doi.org\/10.3390\/antibiotics9110812","journal-title":"Antibiotics"},{"key":"3158_CR28","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.3952","author":"HHT Ko","year":"2017","unstructured":"Ko HHT, Lareu RR, Dix BR, Hughes JD (2017) Statins: antimicrobial resistance breakers or makers? PeerJ. https:\/\/doi.org\/10.7717\/peerj.3952","journal-title":"PeerJ"},{"key":"3158_CR29","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s12016-020-08791-9","volume":"60","author":"K Koushki","year":"2021","unstructured":"Koushki K, Shahbaz SK, Mashayekhi K et al (2021) Anti-inflammatory action of statins in cardiovascular disease: the role of inflammasome and toll-like receptor pathways. Clin Rev Allergy Immunol 60:175\u2013199. https:\/\/doi.org\/10.1007\/s12016-020-08791-9","journal-title":"Clin Rev Allergy Immunol"},{"key":"3158_CR30","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/618081","author":"YS Lee","year":"2012","unstructured":"Lee YS, Jang KA, Cha JD (2012) Synergistic antibacterial effect between silibinin and antibiotics in oral bacteria. J Biomed Biotechnol. https:\/\/doi.org\/10.1155\/2012\/618081","journal-title":"J Biomed Biotechnol"},{"key":"3158_CR31","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1111\/1567-1364.12163","volume":"14","author":"H Li","year":"2014","unstructured":"Li H, Zhang C, Chen Z et al (2014) A promising approach of overcoming the intrinsic resistance of Candida krusei to fluconazole (FLC) \u2212 Combining tacrolimus with FLC. FEMS Yeast Res 14:808\u2013811. https:\/\/doi.org\/10.1111\/1567-1364.12163","journal-title":"FEMS Yeast Res"},{"key":"3158_CR32","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1097\/01.mol.0000191913.16321.60","volume":"16","author":"JK Liao","year":"2005","unstructured":"Liao JK (2005) Clinical implications for statin pleiotropy. Curr Opin Lipidol 16:624\u2013629. https:\/\/doi.org\/10.1097\/01.mol.0000191913.16321.60","journal-title":"Curr Opin Lipidol"},{"key":"3158_CR33","doi-asserted-by":"publisher","unstructured":"Lima W, Parreira A, \u2026 LN-J of, 2018 undefined (2018) Absence of antibacterial, anti-candida, and anti-dengue activities of a surfactin isolated from Bacillus subtilis. researchgate.net. https:\/\/doi.org\/10.4103\/jpnr.JPNR_11_17","DOI":"10.4103\/jpnr.JPNR_11_17"},{"key":"3158_CR34","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.biopha.2018.12.076","volume":"111","author":"WG Lima","year":"2019","unstructured":"Lima WG, Alves-Nascimento LA, Andrade JT, Vieira L, de Azambuja Ribeiro RIM, Thom\u00e9 RG, dos Santos HB, Ferreira JMS, Soares AC (2019) Are the Statins promising antifungal agents against invasive candidiasis? Biomed Pharmacother 111:270\u2013281. https:\/\/doi.org\/10.1016\/j.biopha.2018.12.076","journal-title":"Biomed Pharmacother"},{"key":"3158_CR35","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1128\/AAC.34.9.1660","volume":"34","author":"RT Lorenz","year":"1990","unstructured":"Lorenz RT, Parks LW (1990) Effects of lovastatin (mevinolin) on sterol levels and on activity of azoles in Saccharomyces cerevisiae. Antimicrob Agents Chemother 34:1660\u20131665. https:\/\/doi.org\/10.1128\/AAC.34.9.1660","journal-title":"Antimicrob Agents Chemother"},{"key":"3158_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-015-0934-8","volume":"15","author":"DK Matthaiou","year":"2015","unstructured":"Matthaiou DK, Christodoulopoulou T, Dimopoulos G (2015) How to treat fungal infections in ICU patients. BMC Infectious Diseases 15:1\u20138. https:\/\/doi.org\/10.1186\/s12879-015-0934-8","journal-title":"BMC Infectious Diseases"},{"key":"3158_CR37","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jiac.2015.08.008","volume":"22","author":"M Nagashima","year":"2016","unstructured":"Nagashima M, Yamagishi Y, Mikamo H (2016) Antifungal susceptibilities of Candida species isolated from the patients with vaginal candidiasis. J Infect Chemother 22:124\u2013126. https:\/\/doi.org\/10.1016\/j.jiac.2015.08.008","journal-title":"J Infect Chemother"},{"key":"3158_CR38","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/j.1574-6968.2010.01972.x","volume":"307","author":"I Nyilasi","year":"2010","unstructured":"Nyilasi I, Kocsub\u00e9 S, Krizs\u00e1n K et al (2010) In vitro synergistic interactions of the effects of various statins and azoles against some clinically important fungi. FEMS Microbiol Lett 307:175\u2013184. https:\/\/doi.org\/10.1111\/j.1574-6968.2010.01972.x","journal-title":"FEMS Microbiol Lett"},{"key":"3158_CR39","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/civ933","volume":"62","author":"PG Pappas","year":"2015","unstructured":"Pappas PG, Kauffman CA, Andes DR et al (2015) Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis 62:e1\u2013e50. https:\/\/doi.org\/10.1093\/cid\/civ933","journal-title":"Clin Infect Dis"},{"key":"3158_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2018.26","volume":"4","author":"PG Pappas","year":"2018","unstructured":"Pappas PG, Lionakis MS, Arendrup MC et al (2018) Invasive candidiasis. Nat Rev Dis Prim 4:1\u201320. https:\/\/doi.org\/10.1038\/nrdp.2018.26","journal-title":"Nat Rev Dis Prim"},{"key":"3158_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/FPHYS.2014.00143\/FULL","author":"S Paul","year":"2014","unstructured":"Paul S, Moye-Rowley WS (2014) Multidrug resistance in fungi: regulation of transporter-encoding gene expression. Front Physiol. https:\/\/doi.org\/10.3389\/FPHYS.2014.00143\/FULL","journal-title":"Front Physiol"},{"key":"3158_CR42","doi-asserted-by":"publisher","first-page":"e383","DOI":"10.1016\/S1473-3099(17)30316-X","volume":"17","author":"D Perlin","year":"2017","unstructured":"Perlin D, Rautemaa-RichardsonAlastruez-Izquierdo RD (2017) The global problem of antifungal resistance: prevalence, mechanisms, and management. Lancet Infect Dis 17:e383\u2013e392. https:\/\/doi.org\/10.1016\/S1473-3099(17)30316-X","journal-title":"Lancet Infect Dis"},{"key":"3158_CR43","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.cmi.2019.03.028","volume":"25","author":"KE Pristov","year":"2019","unstructured":"Pristov KE, Ghannoum MA (2019) Resistance of Candida to azoles and echinocandins worldwide. Clin Microbiol Infect 25:792\u2013798. https:\/\/doi.org\/10.1016\/j.cmi.2019.03.028","journal-title":"Clin Microbiol Infect"},{"key":"3158_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2015.01474","volume":"6","author":"EA Rahal","year":"2015","unstructured":"Rahal EA, Constantin WN, Zeidan N, Abdelnoor AM (2015) Atorvastatin reduces the survival of Candida albicans-infected BALB\/c mice. Front Microbiol 6:1\u20138. https:\/\/doi.org\/10.3389\/fmicb.2015.01474","journal-title":"Front Microbiol"},{"key":"3158_CR45","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/NMETH.1818","volume":"9","author":"M Remmert","year":"2012","unstructured":"Remmert M, Biegert A, Hauser A, S\u00f6ding J (2012) HHblits: lightning-fast iterative protein sequence searching by HMM-HMM alignment. Nat Methods 9:173\u2013175. https:\/\/doi.org\/10.1038\/NMETH.1818","journal-title":"Nat Methods"},{"key":"3158_CR46","doi-asserted-by":"publisher","DOI":"10.1128\/MBIO.01755-18","author":"ML Rodrigues","year":"2018","unstructured":"Rodrigues ML (2018) The multifunctional fungal ergosterol. mBio. https:\/\/doi.org\/10.1128\/MBIO.01755-18","journal-title":"mBio"},{"key":"3158_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmed.2016.00011","volume":"3","author":"D Sanglard","year":"2016","unstructured":"Sanglard D (2016) Emerging threats in antifungal-resistant fungal pathogens. Front Med 3:1\u201310. https:\/\/doi.org\/10.3389\/fmed.2016.00011","journal-title":"Front Med"},{"key":"3158_CR48","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4103\/jpnr.JPNR","volume":"9","author":"M Santos","year":"2018","unstructured":"Santos M, Rocha F, Silva D et al (2018) Triazole - chalcones\u202f: lack of antibacterial, anti - candida, and anti - dengue virus activities. J Pharm Negative Results 9:39\u201343. https:\/\/doi.org\/10.4103\/jpnr.JPNR","journal-title":"J Pharm Negative Results"},{"key":"3158_CR49","doi-asserted-by":"publisher","first-page":"3804","DOI":"10.1021\/JM7015057","volume":"51","author":"RW Sarver","year":"2008","unstructured":"Sarver RW, Bills E, Bolton G et al (2008) Thermodynamic and structure guided design of statin based inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase. J Med Chem 51:3804\u20133813. https:\/\/doi.org\/10.1021\/JM7015057","journal-title":"J Med Chem"},{"key":"3158_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AAC.01961-16","volume":"61","author":"B Scorneaux","year":"2017","unstructured":"Scorneaux B, Angulo D, Borroto-Esoda K et al (2017) SCY-078 is fungicidal against Candida species in time-kill studies. Antimicrob Agents Chemother 61:1\u201310. https:\/\/doi.org\/10.1128\/AAC.01961-16","journal-title":"Antimicrob Agents Chemother"},{"key":"3158_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.649026","author":"J Tan","year":"2021","unstructured":"Tan J, Jiang S, Tan L et al (2021) Antifungal activity of minocycline and azoles against fluconazole-resistant Candida species. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2021.649026","journal-title":"Front Microbiol"},{"key":"3158_CR52","unstructured":"Vadivoo V, Dhinakar Raj G, Balasubramanian S, Subramanion S (2018) Elucidation of possible antibacterial effects of statins against primary pathogens of mastitis in cows 7:30\u201333"},{"key":"3158_CR53","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00924-20","author":"G Wall","year":"2020","unstructured":"Wall G, Lopez-Ribot JL (2020) Screening repurposing libraries for identification of drugs with novel antifungal activity. Antimicrob Agents Chemother. https:\/\/doi.org\/10.1128\/AAC.00924-20","journal-title":"Antimicrob Agents Chemother"},{"key":"3158_CR54","doi-asserted-by":"publisher","first-page":"W296","DOI":"10.1093\/NAR\/GKY427","volume":"46","author":"A Waterhouse","year":"2018","unstructured":"Waterhouse A, Bertoni M, Bienert S et al (2018) SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res 46:W296\u2013W303. https:\/\/doi.org\/10.1093\/NAR\/GKY427","journal-title":"Nucleic Acids Res"},{"key":"3158_CR55","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1111\/myc.12204","volume":"57","author":"JY Zhang","year":"2014","unstructured":"Zhang JY, Liu JH, Di LF et al (2014) Vulvovaginal candidiasis: species distribution, fluconazole resistance and drug efflux pump gene overexpression. Mycoses 57:584\u2013591. https:\/\/doi.org\/10.1111\/myc.12204","journal-title":"Mycoses"},{"key":"3158_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-020-4856-8","volume":"20","author":"MR Zhang","year":"2020","unstructured":"Zhang MR, Zhao F, Wang S et al (2020) Molecular mechanism of azoles resistant Candida albicans in a patient with chronic mucocutaneous candidiasis. BMC Infect Dis 20:1\u20136. https:\/\/doi.org\/10.1186\/s12879-020-4856-8","journal-title":"BMC Infect Dis"}],"container-title":["World Journal of Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11274-021-03158-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11274-021-03158-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11274-021-03158-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T10:32:41Z","timestamp":1744194761000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11274-021-03158-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,11]]},"references-count":56,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["3158"],"URL":"https:\/\/doi.org\/10.1007\/s11274-021-03158-4","relation":{},"ISSN":["0959-3993","1573-0972"],"issn-type":[{"value":"0959-3993","type":"print"},{"value":"1573-0972","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,11]]},"assertion":[{"value":"20 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"191"}}